Aug 11, 2026 · 7 min

Asia’s biotech, Singapore and Samsung shares move higher

Chinese Pharma Rallies, Singapore Stocks Rise, Samsung Climbs

The episode shows how drug-development progress, stronger economic expectations and shareholder returns are shaping distinct rallies across Asian markets.

3 key takeaways

1Chinese biotech shares rally as progress on anti-obesity drugs improves investor sentiment.
2Singaporean stocks rise after an upgraded forecast points to stronger economic growth.
3Samsung shares climb on expectations of a major shareholder return package and related technology developments.

Don't miss

Samsung shares rise as investors anticipate a major shareholder return package.

The brief

Stock Movers opens with a concise tour of Asia’s market action, hosted by Stephen Carroll and joined by Anthony Stevens for the regional rundown.

Chinese biotech shares are among the episode’s central stories, gaining momentum as progress on anti-obesity drugs strengthens expectations around the sector.

Singaporean stocks also rise, but for a macroeconomic reason: an upgraded growth forecast gives investors a stronger outlook for the city-state’s economy.

Samsung shares climb on expectations of a major shareholder return package, while the discussion also touches on technology developments involving optical shares.

Taken together, the moves show how Asian equities are responding to different catalysts, from drug pipelines and growth forecasts to corporate capital decisions.

What was said on this episode

9 statements · 9 positive

Anthony Stevenson Asian pharmaPositive1:51
Asian pharma will outperform and provide shelter from AI volatility in the second half.
“pharma emerging here in the second half of the year as a real outperformer and a place to hide from some of this AI volatility”
Listen at 1:51
Anthony Stevenson Trump drug-pricing crackdownPositive2:02
Trump’s drug-pricing crackdown does not affect margins of innovative treatments.
“President Trump's kind of clamp down on drug pricing does not impact the margins in some of these more innovative treatments”
Listen at 2:02
Anthony Stevenson Singapore GDP growth forecastPositive2:23
Singapore raised the upper bound of its GDP growth forecast.
“Singapore's increased the upper range of its GDP growth Forecast”
Listen at 2:23
Anthony Stevenson Singapore AI data centersPositive2:32
Singapore is a regional AI data-center hub.
“Singapore is a low key key AI hub in terms of data centers for the region”
Listen at 2:32
Anthony Stevenson SDI indexPositive2:40
The SDI index has a Sharpe ratio above four.
“the SDI index has a sharp of over 4, which is ridiculously high”
Listen at 2:40
Anthony Stevenson Yang Zijiang ShippingPositive2:50
Yang Zijiang Shipping shares rose almost 10%.
“Yang Zijiang Shipping is up almost 10%”
Listen at 2:50
Anthony Stevenson OCBCPositive3:00
OCBC shares continued above record highs, rising 3%.
“OCBC carries on past its record highs. It's up 3% again today.”
Listen at 3:00
Anthony Stevenson Samsung and Hynix sharesPositive3:55
Samsung shares rose 3.6%, versus Hynix rising 1%.
“Samsung is up 3.6% versus Hynix, up just 1%”
Listen at 3:55
Anthony Stevenson Zhongji, Enolite and EoptolinkPositive4:33
Zhongji, Enolite, and Eoptolink shares rose around 4%.
“Zhongji, Enolite and Eoptolink up around 4% in China and in Hong Kong”
Listen at 4:33

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Featuring

Bloomberg Audio Studios

Mentioned

Asia SSingapore SSamsung CChina

Listen to the full episode and explore every guest, topic, and moment on PodLume.

Listen to the full episode Or get the iOS app